CraniUS Announces a Strategic Partnership with Leading Drug and Device Manufacturer, Medical Produc

CraniUS LLC, an R&D company focused on building breakthrough diagnostics and treatments for neurosurgical patients with chronic brain disease announced a critical partnership with leading FDA-registered drug and device manufacturer, Medical Product Laboratories, Inc (Phila. PA).

As a key partner to CraniUS, MPL will now support testing for the initial stability and safety studies for drug candidates that will be delivered through the company's groundbreaking device enabling long-term and direct medicine administration via CED (convection-enhanced delivery); an innovative method developed to bypass the blood-brain-barrier safely and effectively and forever change the way brain disease is treated. Ongoing testing will directly support upcoming pre-clinical studies in 2023 and a first-in-human study targeted for the back half of 2024.

Read the Full Story Here >